Glucotrack (GCTK) Cost of Revenue (2024 - 2025)
Glucotrack's (GCTK) quarterly Cost of Revenue came in at $120000.0 in Q3 2025, down 4.0% YoY from $125000.0 in Q3 2024, and down 34.07% on a QoQ basis from $182000.0 in Q2 2025.
Glucotrack (GCTK) Cost of Revenue (2024 - 2025) Analysis & Trends
Glucotrack (GCTK) has 2 years of Cost of Revenue data on file, last reported at $120000.0 in Q3 2025.
- Quarterly Cost of Revenue fell 4.0% year-over-year to $120000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $527000.0 (changed N/A YoY) and the FY2020 annual result came in at $73000.0, down 24.74% from the prior year.
- Cost of Revenue declined to $120000.0 in Q3 2025, from $182000.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $182000.0 in Q2 2025 to a low of $100000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 931.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.67 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.13 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 602.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.47 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 543.10 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 807.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 346.10 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 1.93 Bn |
| 10 | Glucotrack | 1.68 Mn | 553,542.53 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 120,000.00 |
| Sep 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 182,000.00 |
| Jun 30, 2025 | 182,000.00 |
| Sep 30, 2024 | 125,000.00 |
| Sep 30, 2024 | 125,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |